AstraZeneca shares owned by Carnegie Capital Asset Management
Quarter-by-quarter ownership of AstraZeneca (AZN) shares owned by Carnegie Capital Asset Management
from 13F filings
Historical chart of Carnegie Capital Asset Management investment in AstraZeneca
Tip: Access up to 7 years of quarterly data
All positions including AstraZeneca held by Carnegie Capital Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in AstraZeneca by Carnegie Capital Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.2M | 18k | 67.35 |
| 2023-09-30 | $1.2M | 18k | 67.72 |
| 2023-06-30 | $1.3M | 18k | 71.57 |
| 2023-03-31 | $1.2M | 18k | 69.41 |
| 2022-12-31 | $1.2M | 17k | 67.80 |
| 2022-09-30 | $941k | 17k | 54.86 |
| 2022-06-30 | $1.1M | 17k | 66.05 |
| 2022-03-31 | $1.1M | 17k | 66.32 |
| 2021-12-31 | $1.0M | 18k | 58.25 |
| 2021-09-30 | $1.1M | 18k | 60.05 |
| 2021-06-30 | $1.1M | 18k | 59.89 |
| 2020-09-30 | $201k | 3.7k | 54.77 |
| 2018-09-30 | $244k | 6.0k | 40.86 |
More positions owned by Carnegie Capital Asset Management
View all positions for Carnegie Capital Asset Management